Search fresh public links, source activity, and ready-to-use post angles for Glp-1 Receptor Agonists.
Fresh curated links around GLP-1 receptor agonists are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
GLP-1 Receptor Agonists Are Associated With Reduced Mortality Following Diabetic Foot Ulcers: A Nationwide Observational Study Jean-Baptiste Bonnet et al Diabetes Care. 2026 Jan 30...
Preoperative GLP-1 receptor agonist use did not impact bariatric surgery outcomes, including weight loss at 1 year, diabetes control and postsurgical complications, according to a...
GLP-1 agonists go beyond treating metabolic disease. They have shown promise in treating MASH, addiction, sleep apnea, and neurodegeneration. The post What can GLP-1s do beside tre...
FRIDAY, Oct 2, 2026 — A real-world study finds GLP-1 medications helped kids, teens and young adults with type 2 diabetes lose weight, as well as improve their blood pressure and b...
New research presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy, from Sept. 28–Oct. 2 examined the real-world use of GLP-1...
Pre-op use of GLP-1 receptor agonists was associated with significantly improved total joint arthroplasty outcomes and risk reduction.
WEDNESDAY, Oct. 7, 2026 — What’s the best way to keep the scale from creeping back up after you stop using a GLP-1 medication? A study published today in the journal Obesity Scien...
FRIDAY, Oct. 2, 2026 — More women are now being prescribed GLP-1 medications like Ozempic and Zepbound after giving birth. A new study finds GLP-1 use among new mothers jumped from...
Glucagon-like peptide-1 (GLP-1) medications work. Semaglutide and tirzepatide help people lose more weight than any pill or shot we’ve had before. The harder problem is everything...
Understanding the connection Reports have emerged linking GLP-1 receptor agonists—medications widely prescribed for […]
MONDAY, Oct. 5, 2026 — An emerging class of weight-loss medications helps users shed pounds but with a much lower risk for gastrointestinal side effects compared to popular GLP-1s,...
There is a lot going on in the GLP-1 space, a market that landed $79 billion last year, and could shift significantly in the coming years. The post Beyond Ozempic: the GLP-1 landsc...
A new study of more than 2 million surgical patients found that those taking GLP-1 medications had lower odds of serious heart complications and infections after surgery. The findi...
New research presented at the 11th UK Congress on Obesity in Sheffield shows GLP-1 medications are reshaping treatment while behavioural support, stigma reduction and system-level...
Children prescribed GLP-1 medications for weight loss, prediabetes or type 2 diabetes are at risk for nutritional deficiencies—diagnosed in nearly one in six patients (16.8%) withi...
Cardiologists are working the weight-loss drugs into more patient conversations.
For a lot of older adults, especially those carrying real cardiovascular or metabolic risk, GLP-1s may offer benefits beyond the number on the scale when under a doctor's supervisi...
Results presented at the American Orthopaedic Foot & Ankle Society Annual Meeting showed GLP-1 receptor agonists were not associated with increased fracture risk in patients wi...
Hailed by some as miracle drugs, GLP-1s have surged in popularity in the past few years. An estimated one out of every eight Americans is now on some version of them and scientists...
From unexpected babies to "Ozempic teeth," the ultra-popular class of GLP-1 medications are turning out to have a few unanticipated side effects. Emerging research shows the drugs,...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.